2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
14
Lung Neoplasms
11
Breast Neoplasms
9
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Stomach Neoplasms
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Wilms Tumor
1
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Interventions
Metformin
7
Testosterone
2
Pioglitazone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Hematologic Tests
×
Clear all
NCT03663062
2020-11-04
OSCAR
South Tyneside and Sunderland NHS Foundation Trust
Completed
1,430 enrolled